<DOC>
	<DOCNO>NCT00433628</DOCNO>
	<brief_summary>This study see HbA1C , usual blood test monitoring blood sugar control diabetic patient , accurate diabetic patient also HIV evaluate alternative method monitor blood sugar prefer HIV infect patient . HIV-infected patient 18 year age old type 2 diabetes high blood sugar may eligible study . Participants two clinic visit ( 1 4 week apart ) NIH Clinical Center . At first visit provide detail medical , social family history blood urine sample collect . Previous blood sugar value also record . At second visit , schedule 1 4 week first visit , blood urine sample collect . Some urine blood sample store future research diabetes , HIV relate condition .</brief_summary>
	<brief_title>Accuracy Hemoglobin A1C Predict Glycemia HIV</brief_title>
	<detailed_description>Diabetes mellitus increasingly recognize among patient live human immunodeficiency virus ( HIV ) infection . At present , unique guideline management diabetes patient HIV . Diabetes population manage accordance national guideline management diabetes patient . However , small study suggest hemoglobin A1C ( HbA1C ) may indicative true glycemic control HIV positive patient . There currently publish prospective study examine ability HbA1C reflect glycemic control HIV positive patient diabetes . Since incidence HIV positive patient lipodystrophy , glucose intolerance , diabetes steadily increase widespread use highly active antiretroviral therapy ( HAART ) , question best monitor hyperglycemia patient important one . This study , prospective cross-sectional study 100 patient , seek collect preliminary data determine HbA1C appropriately reflect plasma glucose HIV positive patient . Patients HIV diabetes hyperglycemia fast random plasma glucose HbA1C collect normal diabetes patient care . They also two validate alternate marker glycemic control drawn , fructosamine Glycomark [ R ] , determine well marker may reflect actual glycemia . Fructosamine represent measure protein glycosylation whereas Glycomark [ R ] monosaccharide plasma competitively inhibit renal tubule glucose reflect day-to-day hyperglycemia . In addition , hemolysis assess investigate one potential mechanism HbA1C may less accurate representation glycemia patient . The determination value HbA1C marker glycemia HIV positive patient diabetes assist monitoring management unique population diabetes . The measurement glycemic marker may provide evidence towards potential superior marker glycemia patient , study provide insight possible mechanism HbA1C discrepancy .</detailed_description>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>INCLUSION CRITERIA : Documented + HIV ELISA . Diabetes mellitus ( DM ) define : Documented diagnosis type 2 diabetes mellitus FPG great equal 126 mg/dl two occasion casual blood glucose great equal 200 mg/dL symptom diabetes . Impaired Fasting Glucose ( IFG ) define : FPG great equal 100 mg/dl less 126 mg/dl one occasion within past year . Age 18+ , male female . EXCLUSION CRITERIA : Type 1 Diabetes . Known current pregnancy pregnancy within 6 mo . Documented hemoglobinopathy . Changes antiretroviral therapy within 3 month . History anemia ( Hb le 9g/dL past 6 month ) . Active opportunistic Infection opportunistic Infection within 3 mo . Creatine great 1.8 mg/dL know end stage renal disease ( ESRD ) . Changes diabetes therapy within 3 mo ( exclude dose adjustment ) . Subject deem unable comply requirement study participation . Use oral corticosteroid within past 3 mo ( stable dose inhaled steroid allow ) . Blood transfusion within 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 25, 2009</verification_date>
	<keyword>Hemoglobin A1C</keyword>
	<keyword>HIV</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Diabetes Type 2</keyword>
	<keyword>Hyperglycemia</keyword>
</DOC>